41. Paediatric rheumatology care in Europe: setting children and adolescents into focus.
作者: Dirk Foell.;Marija Jelusic.;Erdal Sag.;Alessandro Consolaro.;Michael Poelzl.;Jordi Anton.
来源: Lancet Rheumatol. 2026年
Despite major scientific advances, delivering high-quality care for children with inflammatory rheumatic and musculoskeletal diseases remains challenging. The field of paediatric rheumatology lies at the intersection of different disciplines, and requires excellent highly specialised medical expertise based on rapidly deepening knowledge in rheumatology and immunology. At the same time, this field relies on compassionate paediatricians understanding the needs of developing children as a vulnerable population. Training pathways and professional recognition vary widely between countries, and formal subspecialty accreditation is available inconsistently. Based on a Europe-wide expert survey, this Viewpoint examines why paediatric rheumatology is still not universally recognised as a distinct subspecialty and how insufficient access to formal accreditation leads to fragmented representation and low visibility of this discipline. We argue that stronger international advocacy involving patients and families is urgently required to support the sustainable development of the field and to ensure equitable, evidence-based, developmentally and psychologically appropriate care for all affected children.
42. Weight loss ameliorates symptoms of osteoarthritis and is correlated with alterations in soluble bone and cartilage markers: an analysis of patient-reported outcomes and biomarkers.
作者: Anne-Christine Bay-Jensen.;Khaled Mohamed.;Peder Frederiksen.;Asger Bihlet.;Christian Thudium.;Kim Henriksen.;Morten Karsdal.
来源: BMC Rheumatol. 2026年10卷1期
Drug development for osteoarthritis (OA) has faced significant challenges, mainly due to the lack of alignment between joint structure observations and patient-reported outcomes (PROs), such as pain. Weight loss has been linked to positive effects on symptomatic outcomes. Blood-based biomarkers indicating collagen and extracellular matrix turnover can be used to measure injury severity in specific tissues, offering a more precise assessment of disease progression. This study aimed to explore the relationship between obesity and PROs and its impact on serum and urinary biomarkers of bone (CTX-I and osteocalcin), synovial (type III collagen degradation and C3M), and cartilage (type II collagen degradation, CTX-II, and C2M) turnover.
43. Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement.
作者: Laura Ross.;Andrew T Burns.;André La Gerche.;Dylan Hansen.;J Gerry Coghlan.;Wendy Stevens.;David Prior.;Alan Pham.;Penny McKelvie.;Chiara Bellocchi.;Yolanda Braun Moscovici.;Cosimo Bruni.;Patricia Carreira.;Tracy Frech.;Sabrina Hoa.;Marie Hudson.;Vivien Hsu.;Andrea Hsiu Ling Low.;Marco Matucci-Cerinic.;Benjamin Medina Fonseca.;Sue-Ann Ng.;Tatiana Rodriguez Reyna.;Joanne Sahhar.;Mohamed Talaat.;Susanna Proudman.;Alessandra Vacca.;Murray Baron.;Mandana Nikpour.; .
来源: Rheumatology (Oxford). 2026年65卷3期
Systemic sclerosis-associated heart involvement (SHI) is an enigmatic disease manifestation associated with high mortality. The Scleroderma Clinical Trials Consortium (SCTC) Cardiac Working Group developed SHI classification criteria to enable systematic investigation of this condition.
44. Temporomandibular joint disorders in patients with systemic sclerosis: a cross-sectional study.
作者: Kiana Azadpeyma.;Seyed Habib Zayeni.;Pooneh Ghavidel Parsa.;Pedram Hajibagheri.;Maryam Basirat.
来源: BMC Rheumatol. 2026年10卷1期
Systemic sclerosis (SSc) is a connective tissue disease that can affect multiple organs, including the musculoskeletal system and the temporomandibular joint (TMJ). This study aimed to determine the frequency and clinical characteristics of temporomandibular disorders (TMD) among patients with SSc.
45. Short-course prednisone and methotrexate in a cohort of patients with polymyalgia rheumatica: a potential therapeutic approach.
作者: Edoardo Conticini.;Raffaele Truscelli.;Silvia Grazzini.;Paolo Falsetti.;Caterina Baldi.;Alessandra Cartocci.;Luca Cantarini.;Bruno Frediani.
来源: BMC Rheumatol. 2026年10卷1期
The optimal treatment of polymyalgia rheumatica (PMR) is far from being fully elucidated. Only a few trials explored the role of conventional DMARDs: none of them adequately ruled out subclinical giant cell arteritis (GCA). The aim of this study was to assess whether the precocious administration of methotrexate (MTX) and a short course of glucocorticoids (GCs) could be safe and effective in recently diagnosed PMR.
46. The rheumatry registry: design and data collection methods.
作者: Mehrdad Mahalleh.;Mahdi Mahmoudi.;Mohammad Tanhaei.;Ahmadreza Jamshidi.
来源: BMC Rheumatol. 2026年10卷1期
Rheumatic disease registries systematically collect real-world longitudinal data, improving patient care and research. Despite the high burden of rheumatic diseases, national registries are scarce in the Middle East. Rheumatology Research Center, with support from Iran’s Ministry of Health, launched Rheumatry in 2016 as the country’s first national rheumatic disease registry.
47. CD72 downregulation on DN2 B cells is associated with disease activity and resistance to rituximab in systemic lupus erythematosus.
作者: Kittikorn Wangriatisak.;Wenqi Huang.;Giorgio Sechi.;Vilija Oke.;Karine Chemin.;Caroline Grönwall.;Iva Gunnarsson.;Vivianne Malmström.;Francesca Faustini.
来源: Rheumatology (Oxford). 2026年65卷3期
In SLE, expanded B cell subtypes like double-negative 2 (DN2) may harbour autoreactivity, which may be linked to impaired checkpoint regulation. We investigated checkpoint molecule CD72 on B cells, its clinical associations, and dynamic changes upon rituximab (RTX) treatment.
48. Psychometric validation of the Bulgarian Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire: linking quality of life with disease activity in axial spondyloarthritis.
作者: Daliya Tsvetanova Pencheva.;Ellie Johnstone.;Mariusz T Grzeda.;Vladimira Boyadzhieva.;Nikolay Stoilov.;Mariana Ivanova.
来源: BMC Rheumatol. 2026年10卷1期
Assessing quality of life in patients with axial spondyloarthritis (axSpA) is essential for capturing the full burden of the disease beyond clinical and imaging findings. Quality of life measures support clinicians in identifying unmet patient needs and informing treatment decisions. The aim of this study was to develop and validate the first Bulgarian version of the Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire.
49. Effectiveness of IV cyclophosphamide and mycophenolate mofetil in the treatment of childhood-onset lupus nephritis in a resource-limited setting.
作者: Adrienne Katrin M Guiang-Valerio.;Ma Theresa M Collante.;Christine B Bernal.
来源: BMC Rheumatol. 2026年10卷1期
Lupus nephritis (LN) is a major cause of morbidity in childhood-onset systemic lupus erythematosus (cSLE). Cyclophosphamide (CYC) and mycophenolate mofetil (MMF) are recommended first-line induction therapies, yet comparative pediatric real-world data, particularly from Asian populations, remain limited. This study compared the effectiveness of CYC and MMF for induction of renal remission and evaluated patterns and predictors of treatment switching among Filipino children with LN.
50. A randomised open-label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot).
作者: Christopher P Denton.;Philip Yee.;Medha Kanitkar.;Hannah Sims.;Charlotte Clarke.;Saiam Ahmed.;Voon H Ong.;Francesco Del Galdo.;John D Pauling.;Marina E Anderson.;Muditha Samaranayaka.;Michael Hughes.;Smita Bhat.;Bridget Griffiths.;Maya H Buch.;Ariane L Herrick.;David D'Cruz.;Madelon C Vonk.;Nick Freemantle.;Hakim-Moulay Dehbi.
来源: Rheumatology (Oxford). 2026年65卷3期
Mycophenolate mofetil (MMF) is routinely used in early diffuse cutaneous systemic sclerosis (dcSSc) but not in limited cutaneous (lc)SSc. This may miss an opportunity to slow disease progression. MINIMISE-Pilot tested the feasibility of an open-label event-driven randomised trial of MMF vs no immunosuppression in lcSSc.
51. Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational study.
作者: Gabriele Domenico Gallina.;Marco Lanzillotta.;Sara Maggioni.;Adriana Cariddi.;Giulia Danè.;Ayşe Nur Bayındır Akbaş.;Askin Ates.;Alvise Berti.;Enrico Brunetta.;Ayse Cefle.;Emanuele Chiara.;Edoardo Conticini.;Vincent Cottin.;Paolo Delvino.;Filippo Fagni.;Gözde Sevgi Kart Bayram.;Ömer Karadağ.;Gabriella Moroni.;Sergey Moiseev.;Sara Monti.;Tahir Saygın Öğüt.;Pavel Novikov.;Roberto Padoan.;Luca Iorio.;Federica Davanzo.;Michelangelo Tesi.;Luca Quartuccio.;Ayten Yazici.;Marco Matucci-Cerinic.;Lorenzo Dagna.;Luca Moroni.; .
来源: Rheumatology (Oxford). 2026年65卷3期
Subglottic stenosis (SGS) is a challenging manifestation of granulomatosis with polyangiitis (GPA), often relapsing and poorly responsive to immunosuppressive treatment. Current guidelines lack specific recommendations for SGS management and evidence is limited. This study aimed to identify features of SGS associated with a more aggressive course and to assess the efficacy of available treatments in preventing relapses.
52. Trends in mortality due to GPA/MPA across Europe: insights from a decade of death registrations.
作者: Kathryn Biddle.;Adam Taylor.;Thomas J Trimble.;Matthew J Grainge.;Peter Lanyon.;James Galloway.;Fiona A Pearce.
来源: Rheumatology (Oxford). 2026年65卷3期
To examine contemporary trends in mortality due to granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in Europe.
53. Hormonal transitions across the lifespan shape susceptibility to Sjogren's disease.
Sjogren's disease (SjD) shows a strong female predominance, but the contribution of age-related hormone changes to this sex bias remains uncertain. We investigated whether natural hormonal transitions across the lifespan align with variation in male and female prevalence of SjD.
54. Advancing drug development for systemic sclerosis by prioritizing findings from human genetic association studies.
作者: Michael Hughes.;Zsuzsanna H McMahan.;Shervin Assassai.;Christopher P Denton.;Rui Providencia.
来源: Rheumatology (Oxford). 2026年65卷3期
SSc is a rare rheumatological disease associated with significant morbidity and mortality. Despite significant recent international clinical trial activity, the yield of approved compounds has been disappointingly low. Our aim was to identify and prioritize potential 'druggable' targets with insights from human genetics, by integrating the available evidence with publicly available bioinformatics sources relevant for SSc drug development.
55. Prevalence of effective contraceptive use among patients with rheumatic diseases: a descriptive study.
作者: Mayalen Uthurriague.;Charlotte Delattre.;Thomas Barnetche.;Estibaliz Lazaro.;Marie-Elise Truchetet.;Claude Hocke.;Nadia Mehsen-Cetre.;Valérie Bernard.;Christophe Richez.
来源: BMC Rheumatol. 2026年10卷1期
Systemic autoimmune and chronic inflammatory rheumatic diseases predominantly affect childbearing women. These women are at greater risk for pregnancy complications stemming from both the underlying disease and the treatments required to manage it. This cross-sectional study aimed to assess the prevalence of effective contraceptive use across a wide range of diseases including systemic lupus, systemic sclerosis, Sharp syndrome, Sjögren’s disease, rheumatoid arthritis, and spondyloarthritis.
56. Artificial Intelligence (AI) in rheumatology: a comparative evaluation of the ChatGPT and DeepSeek application.
The continuous increase in Artificial Intelligence (AI) applications in various areas of human life has brought about great changes in many sciences, among which is the health sector. ChatGPT and DeepSeek belong to the category of Large Language Models (LLMs) developed by Artificial Intelligence (AI) using supervised and reinforcement learning techniques. The aim of this article is to evaluate the accuracy and consistency of ChatGPT and DeepSeek models in the diagnosis and treatment of two rheumatologic diseases, ankylosing spondylitis (axSpA) and psoriatic arthritis (PsA).
57. "What do you want this information for?": cognitive interviews with arthritis researchers to inform the development of a health equity-focused demographic survey for outcomes research.
作者: Megan M Thomas.;Niki Oveisi.;Charlene E Ronquillo.;Mark Harrison.;Cheryl Barnabe.;Codie Primeau.;J Antonio Avina-Zubieta.;Anna Samson.;Michael Kuluva.;Natasha Trehan.;Nikki Bhatti.;Aniruddha Methi.;Mary A De Vera.
来源: BMC Rheumatol. 2026年10卷1期
Arthritis research in Canada has historically lacked focus on equity, diversity, and inclusion (EDI), as studies show limited reporting of equity-related factors and underrepresentation of participants who are historically from underserved communities. To address this, the objective of this study was to gather feedback from arthritis researchers in Canada to inform the development of a health equity-focused demographic survey for arthritis outcomes research.
58. Digital interactions with the pharmaceutical industry: a qualitative focus group study on the perspectives of rheumatology care providers in Germany.
作者: Susann May.;Amina Jeleskovic-Öztürk.;Hannah Meisberger.;Finnja Stangel.;Katharina Boy.;Niklas Ohm.;Greta Nordmann.;Robert Darkow.;Johannes Knitza.;Felix Muehlensiepen.
来源: BMC Rheumatol. 2026年10卷1期
Digitalization is reshaping healthcare delivery, including how physicians and the pharmaceutical industry interact. Rheumatology care is a particularly dynamic field, where digital technologies are increasingly integrated into both clinical care and pharmaceutical engagement. Despite growing digital collaboration, little is known about healthcare professionals’ perspectives on these developments.
59. Preferences, experiences and needs regarding tobacco cessation expressed among patients with rheumatoid arthritis: a qualitative study.
作者: Maria A Lopez-Olivo.;Sheneze Madramootoo.;Johncy J Kachira.;Kaleb Michaud.;Rebecca Schumacher.;Paul Cinciripini.;Maria E Suarez-Almazor.
来源: BMC Rheumatol. 2026年10卷1期
Smoking presents significant challenges for individuals with rheumatoid arthritis (RA) yet understanding of their smoking habits and perceptions remains limited. This study explores preferences regarding tobacco cessation strategies, barriers to success in cessation, and perceived needs in this population.
60. NRAS and SREBF1 identified as mitophagy-associated risk genes for rheumatoid arthritis through interpretable machine learning and experimental validation studies.
作者: Hongman Li.;Peng Liu.;Xiao Han.;Shengyong Si.;ZhiJing Li.;Chun Zhao.;Xue Zhao.;Xue Zhou.;Mengdie Liu.
来源: BMC Rheumatol. 2026年10卷1期
Mitophagy has been implicated in the pathogenesis of rheumatoid arthritis (RA), particularly in fibroblast-like synoviocytes (FLSs), yet its regulatory landscape and diagnostic relevance remain incompletely understood. This study aimed to identify mitophagy-associated genes (MRGs) in RA and to explore their potential diagnostic value using integrative bioinformatics and interpretable machine learning approaches.
|